- In September 2022, Olympus introduced the Guardenia Contained Extraction System, an advanced solution for gynecological procedures. Manufactured by Advanced Surgical Concepts (ASC) Ltd. in Bray, Ireland, Guardenia expands Olympus' tissue extraction portfolio, enhancing safety and efficiency in minimally invasive surgeries through innovative design and reliable technology
- In June 2022, UroViu Corp launched the Hystero-V, a 12-Fr, semi-rigid, single-use hysteroscope compatible with its Always Ready endoscopy platform. Featuring a hydrophilic coating, it ensures gentle insertion and superior visualization, facilitating effective intra-uterine examinations with enhanced precision and patient comfort
Frequently Asked Questions
The market is segmented based on Segmentation, By Cancer Type (Vulvar Squamous Cell Carcinoma, Vulvar Melanoma, Adenocarcinoma and Basal Cell Carcinoma), Treatment Type (Chemotherapy, Surgery, Laser Surgery, Excision, Skinning Vulvectomy, Radical Vulvectomy, Radiation Therapy, and Biologic Therapy), End Users (Hospitals and Clinics, Research and Academic Institutes and Others) – Industry Trends and Forecast to 2032
.
The Global Vulvar Cancer Market size was valued at USD 605.70 USD Billion in 2024.
The Global Vulvar Cancer Market is projected to grow at a CAGR of 6.11% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.